{
    "organizations": [],
    "uuid": "827fe866531e6b3c67847bf681e1918511faef1b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-guangzhou-baiyunshan-pharma-to-inv/brief-guangzhou-baiyunshan-pharma-to-invest-800-mln-yuan-each-in-two-health-industry-funds-idUSH9N1PZ02N",
    "ord_in_thread": 0,
    "title": "Guangzhou Baiyunshan Pharma To Invest 800 Mln Yuan Each In Two Health Industry Funds",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 13 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd:\n* SAYS IT PLANS TO SET UP TWO INVESTMENT JVS AND TO INVEST UP TO 800 MILLION YUAN ($126.19 million) EACH IN TWO HEALTH INDUSTRY FUNDS Source text in Chinese: bit.ly/2HaSygj ; bit.ly/2suOXGJ Further company coverage: ($1 = 6.3398 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-02-13T20:08:00.000+02:00",
    "crawled": "2018-02-14T12:53:33.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "guangzhou",
        "baiyunshan",
        "pharmaceutical",
        "holding",
        "co",
        "ltd",
        "say",
        "plan",
        "set",
        "two",
        "investment",
        "jv",
        "invest",
        "million",
        "yuan",
        "million",
        "two",
        "health",
        "industry",
        "fund",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "chinese",
        "yuan",
        "renminbi",
        "reporting",
        "hong",
        "kong",
        "newsroom",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}